Curis, Inc. (CRIS) Reports In-Line Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Curis' (CRIS) Q1 Results Flat; Erivedge Growth, Pipeline Remain in Focus - Roth
May 8, 2014 2:18 PM EDTRoth Capital comments on Curis, Inc. (Nasdaq: CRIS) following the company's Q1 report, which was out ahead of the bell Thursday. Briefly, Curis posted an in-line loss of 8 cents per share.
Analyst Joseph Pantginis commented, After the FDA removed the partial clinical hold on the Phase I CUDC-427 monotherapy study in March, CRIS is preparing to re-open the study under the amended protocol. CRIS plans to initiate... More
